1. Home
  2. ADAG vs SUJA Comparison

ADAG vs SUJA Comparison

Compare ADAG & SUJA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Adagene Inc.

ADAG

Adagene Inc.

N/A

Current Price

$2.05

Market Cap

222.2M

Sector

Health Care

ML Signal

N/A

Logo Suja Life Inc. Class A Common Stock

SUJA

Suja Life Inc. Class A Common Stock

N/A

Current Price

$9.96

Market Cap

215.3M

ML Signal

N/A

Company Overview

Basic Information
Metric
ADAG
SUJA
Founded
2011
2012
Country
China
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Beverages (Production/Distribution)
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
222.2M
215.3M
IPO Year
2020
2026

Fundamental Metrics

Financial Performance
Metric
ADAG
SUJA
Price
$2.05
$9.96
Analyst Decision
Strong Buy
Buy
Analyst Count
6
7
Target Price
$9.91
★ $18.40
AVG Volume (30 Days)
★ 232.4K
160.7K
Earning Date
08-12-2026
11-10-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$10.73
Revenue Next Year
$129.59
$12.60
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.50
$5.59
52 Week High
$4.85
$12.42

Technical Indicators

Market Signals
Indicator
ADAG
SUJA
Relative Strength Index (RSI) 36.54 47.53
Support Level N/A $9.51
Resistance Level $3.50 $10.96
Average True Range (ATR) 0.24 0.63
MACD -0.02 -0.09
Stochastic Oscillator 13.53 30.20

Price Performance

Historical Comparison
ADAG
SUJA

About ADAG Adagene Inc.

Adagene Inc is a platform-driven, clinical-stage biotechnology company focused on the discovery and development of novel antibody-based cancer immunotherapies. The Company leverages computational biology to design and develop novel antibodies. Powered by its Dynamic Precision Library (DPL) platform, which fuels its NEObody, SAFEbody, and POWERbody technologies, it is developing a pipeline of immunotherapies. Its candidate, ADG126 (muzastotug), an anti-CTLA-4 SAFEbody, is in phase 1b/2 and phase 2 clinical development for metastatic microsatellite-stable colorectal cancer. Its clinical-stage products include ADG126 and ADG116, investigational fully human anti-CTLA-4 mAbs generated through SAFEbody and NEObody technologies.

About SUJA Suja Life Inc. Class A Common Stock

Suja Life Inc operates a beverage platform focused on producing and selling products such as cold-pressed juices, wellness shots, and functional sodas. Its portfolio includes brands such as Suja Organic, Vive Organic, and Slice. The Company operates and manages its business in two operating segments, which are also reportable segments: i) Suja Core: It produces and distributes cold-pressed fresh juice and cold-pressed juice shots. ii) Emerging Brands: It consists of recently acquired or launched brands and products that are still in the early stages of revenue scale, market development, or distribution build-out. The majority of revenue is derived from Suja Core.

Share on Social Networks: